82_FR_21482 82 FR 21395 - National Cancer Institute; Notice of Meeting

82 FR 21395 - National Cancer Institute; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 87 (May 8, 2017)

Page Range21395-21395
FR Document2017-09297

Federal Register, Volume 82 Issue 87 (Monday, May 8, 2017) 
[Federal Register Volume 82, Number 87 (Monday, May 8, 2017)]
[Notices]
[Page 21395]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-09297]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
National Cancer Institute Clinical Trials and Translational Research 
Advisory Committee.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting. The meeting will also be videocast and can be 
accessed from the NIH Videocasting and Podcasting Web site (http://videocast.nih.gov/).

    Name of Committee: National Cancer Institute Clinical Trials and 
Translational Research Advisory Committee.
    Date: July 12, 2017.
    Time: 8:00 a.m. to 3:00 p.m.
    Agenda: Strategic Discussion of NCI's Clinical and Translational 
Research Programs.
    Place: National Institutes of Health, Building 31, C-Wing, 6th 
Floor, Room 9 and 10, 31 Center Drive, Bethesda, MD 20892.
    Contact Person: Sheila A. Prindiville, MD, MPH, Director, 
Coordinating Center for Clinical Trials, National Institutes of 
Health, National Cancer Institute, Coordinating Center for Clinical 
Trials, 9609 Medical Center Drive, Room 6W136, Rockville, MD 20850, 
240-276-6173, [email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit. Information is also available on the Institute's/Center's 
home page: http://deainfo.nci.nih.gov/advisory/ctac/ctac.htm, where 
an agenda and any additional information for the meeting will be 
posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: May 3, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-09297 Filed 5-5-17; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 82, No. 87 / Monday, May 8, 2017 / Notices 21395 Contact Person: Alan P. Koretsky, Ph.D., the statement to the Contact Person listed on Time: 8:00 a.m. to 3:00 p.m. Scientific Director, Division of Intramural this notice. The statement should include the Agenda: Strategic Discussion of NCI’s Research, National Institute of Neurological name, address, telephone number and when Clinical and Translational Research Disorders and Stroke, NIH, 35 Convent Drive, applicable, the business or professional Programs. Room 6A 908, Bethesda, MD 20892, (301) affiliation of the interested person. Place: National Institutes of Health, 435–2232, koretskya@ninds.nih.gov. In the interest of security, NIH has Building 31, C-Wing, 6th Floor, Room 9 and (Catalogue of Federal Domestic Assistance instituted stringent procedures for entrance 10, 31 Center Drive, Bethesda, MD 20892. Program Nos. 93.853, Clinical Research onto the NIH campus. All visitor vehicles, Contact Person: Sheila A. Prindiville, MD, Related to Neurological Disorders; 93.854, including taxicabs, hotel and airport shuttles MPH, Director, Coordinating Center for Biological Basis Research in the will be inspected before being allowed on Clinical Trials, National Institutes of Health, Neurosciences, National Institutes of Health, campus. Visitors will be asked to show one National Cancer Institute, Coordinating HHS). form of identification (for example, a Center for Clinical Trials, 9609 Medical government-issued photo ID, driver’s license, Center Drive, Room 6W136, Rockville, MD Dated: May 3, 2017. or passport) and to state the purpose of their 20850, 240–276–6173, prindivs@ Sylvia L. Neal, visit. mail.nih.gov. Program Analyst, Office of Federal Advisory Information is also available on the Any interested person may file written Committee Policy. Institute’s/Center’s home page: http:// comments with the committee by forwarding [FR Doc. 2017–09295 Filed 5–5–17; 8:45 am] acd.od.nih.gov, where an agenda and any the statement to the Contact Person listed on BILLING CODE 4140–01–P additional information for the meeting will this notice. The statement should include the be posted when available. name, address, telephone number and when (Catalogue of Federal Domestic Assistance applicable, the business or professional DEPARTMENT OF HEALTH AND Program Nos. 93.14, Intramural Research affiliation of the interested person. HUMAN SERVICES Training Award; 93.22, Clinical Research In the interest of security, NIH has Loan Repayment Program for Individuals instituted stringent procedures for entrance National Institutes of Health from Disadvantaged Backgrounds; 93.232, onto the NIH campus. All visitor vehicles, Loan Repayment Program for Research including taxicabs, hotel, and airport shuttles Office of the Director, National Generally; 93.39, Academic Research will be inspected before being allowed on Enhancement Award; 93.936, NIH Acquired campus. Visitors will be asked to show one Institutes of Health; Notice of Meeting Immunodeficiency Syndrome Research Loan form of identification (for example, a Pursuant to section 10(a) of the Repayment Program; 93.187, Undergraduate government-issued photo ID, driver’s license, Federal Advisory Committee Act, as Scholarship Program for Individuals from or passport) and to state the purpose of their amended (5 U.S.C. App.), notice is Disadvantaged Backgrounds, National visit. Information is also available on the Institutes of Health, HHS) Institute’s/Center’s home page: http:// hereby given of a meeting of the Advisory Committee to the Director, Dated: May 3, 2017. deainfo.nci.nih.gov/advisory/ctac/ctac.htm, where an agenda and any additional National Institutes of Health. Anna Snouffer, information for the meeting will be posted The meeting will be open to the Deputy Director, Office of Federal Advisory when available. public, with attendance limited to space Committee Policy. (Catalogue of Federal Domestic Assistance available. Individuals who plan to [FR Doc. 2017–09296 Filed 5–5–17; 8:45 am] Program Nos. 93.392, Cancer Construction; attend and need special assistance, such BILLING CODE 4140–01–P 93.393, Cancer Cause and Prevention as sign language interpretation or other Research; 93.394, Cancer Detection and reasonable accommodations, should Diagnosis Research; 93.395, Cancer notify the Contact Person listed below DEPARTMENT OF HEALTH AND Treatment Research; 93.396, Cancer Biology in advance of the meeting. HUMAN SERVICES Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Name of Committee: Advisory Committee National Institutes of Health Cancer Control, National Institutes of Health, to the Director, National Institutes of Health. HHS) Date: June 8, 2017. Time: 9:00 a.m. to 5:30 p.m. National Cancer Institute; Notice of Dated: May 3, 2017. Agenda: NIH Director’s Report, ACD Meeting Melanie J. Pantoja, Working Group Reports. Pursuant to section 10(a) of the Program Analyst, Office of Federal Advisory Place: National Institutes of Health, Porter Federal Advisory Committee Act, as Committee Policy. Neuroscience Research Center, Building 35, Room 640, 35 Convent Drive, Bethesda, MD amended (5 U.S.C. App.), notice is [FR Doc. 2017–09297 Filed 5–5–17; 8:45 am] 20892. hereby given of a meeting of the BILLING CODE 4140–01–P Contact Person: Gretchen Wood, Staff National Cancer Institute Clinical Trials Assistant, National Institutes of Health, and Translational Research Advisory Office of the Director, One Center Drive, Committee. DEPARTMENT OF HEALTH AND Building 1, Room 126, Bethesda, MD 20892, The meeting will be open to the HUMAN SERVICES 301–496–4272, Woodgs@od.nih.gov. public, with attendance limited to space Name of Committee: Advisory Committee National Institutes of Health available. Individuals who plan to to the Director, National Institutes of Health. Date: June 9, 2017. attend and need special assistance, such National Institute of Diabetes and Time: 9:00 a.m. to 1:00 p.m. as sign language interpretation or other Digestive and Kidney Diseases; Notice Agenda: Other Business of the Committee. reasonable accommodations, should of Closed Meetings Place: National Institutes of Health, Porter notify the Contact Person listed below Neuroscience Research Center, Building 35, in advance of the meeting. The meeting Pursuant to section 10(d) of the asabaliauskas on DSK3SPTVN1PROD with NOTICES Room 640, 35 Convent Drive, Bethesda, MD will also be videocast and can be Federal Advisory Committee Act, as 20892. accessed from the NIH Videocasting and amended (5 U.S.C. App.), notice is Contact Person: Gretchen Wood, Staff Assistant, National Institutes of Health, Podcasting Web site (http:// hereby given of the following meetings. Office of the Director, One Center Drive, videocast.nih.gov/). The meetings will be closed to the Building 1, Room 126, Bethesda, MD 20892, Name of Committee: National Cancer public in accordance with the 301–496–4272, Woodgs@od.nih.gov. Institute Clinical Trials and Translational provisions set forth in sections Any interested person may file written Research Advisory Committee. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., comments with the committee by forwarding Date: July 12, 2017. as amended. The grant applications and VerDate Sep<11>2014 18:27 May 05, 2017 Jkt 241001 PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 E:\FR\FM\08MYN1.SGM 08MYN1


Document Created: 2017-05-06 02:21:30
Document Modified: 2017-05-06 02:21:30
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesJuly 12, 2017.
FR Citation82 FR 21395 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR